At AD/PD 2026, Roche announced that patients treated with prasinezumab for five years demonstrated a sustained slowing of ...
Calamos CPZ reported a Q4 total return of -2.05% on NAV as the fund shifted exposure from AI beneficiaries to pro-growth ...
Q4 2025 Earnings Call March 26, 2026 4:00 AM EDTCompany ParticipantsMichael Paska - Chief Investor Relations Officer ...
Morning Overview on MSN
Study finds Bahamas sharks had caffeine, painkillers and cocaine in blood
Sharks cruising the clear waters of the Bahamas have been found with traces of human drugs in their blood, including cocaine, ...
Morning Overview on MSN
Trial: Estradiol patches match injections for prostate cancer care
A randomized phase III trial run out of the United Kingdom has found that estradiol skin patches suppress testosterone as ...
I hated the first digital wall calendar I tried. I tried the Hearth Display last year and was left unimpressed, but to my ...
Reverse Engineering of Manufactured Parts Simplified with the New Advanced VisionGauge® ‘Snake’ Tool
The VisionGauge® “Snake” tool utilizes automatic edge-following technology for fast and high-accuracy reverse engineering of manufactured parts and models.
Explore digital PCR’s potential, how the technology has transformed life science research, the challenges it faces and what ...
With AI content, partisan framing, and viral rumors flooding our feeds, knowing how to verify what you see online is now a ...
Diploma Upgrades FY Outlook After “Very Strong” H1, Lifts Organic Growth to 6%–9% and Margins to 25%
Diploma (LON:DPLM) upgraded its full-year trading expectations during a conference call led by CEO Johnny Thomson, citing a “very strong” first half and confidence in momentum into the second half.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results